anonymous
Guest
anonymous
Guest
I don’t believe you. Where? Which ones?
Whiteout stating the clinics we aren’t buying it.
You are a moron. Obviously not in your territory
I don’t believe you. Where? Which ones?
Whiteout stating the clinics we aren’t buying it.
"Mass General Brigham has decided that it will not provide aducanumab (Aduhelm™) for the treatment of Alzheimer’s disease at this time. Like all other drugs used within Mass General Brigham, aducanumab was subject to evaluation by the Mass General Brigham Pharmacy and Therapeutics Committee, a multidisciplinary panel of experts from across the academic health system, that serves as decision-making body to Mass General Brigham on formulary management. The evaluation included a thorough review of clinical, economic, and operational considerations. This decision was based on the current data regarding aducanumab’s safety and efficacy. We understand that this may be difficult news for some of our patients. However, we fully support continued evaluation of this medication and should new data become available we will re-evaluate this decision"
You mean Mass General doesn’t want to pay for a drug that’s wildly overpriced, doesn’t work and could kill people? I’m stunned.